Are exhausted T cells functionless? Absolutely not! We found that dysfunctional T cells are key initiators of early tissue responses to PD-1 blockade and equipped to rapidly regain anti-tumor function via restoration of translational control. See new preprint from the lab led by Paulien Kaptein

Congratulations @jacqjacobs.bsky.social @riklindeboom.bsky.social @danielathommen.bsky.social on receiving a ZonMw open competition

Very proud of our postdoc @christinamt.bsky.social @nkinl.bsky.social who was awarded an EACR-Mark Foundation Postdoctoral Fellowship! Congratulations to the other awardees and thanks to @helloeacr.bsky.social and @themarkfdn.bsky.social for this fantastic support!

Well done to the first recipients of the EACR-Mark Foundation postdoc fellowships 🎉🎊 And a happy coincidence that all three awardees are women scientists in the labs of three women PIs 🙌 #WomeninSTEM #WomeninScience 👩‍🔬👩🏻‍🔬🧪 @themarkfdn.bsky.social @helloeacr.bsky.social @juliemmazet.bsky.social

For those who couldn't attend the new #AACRIO25 meeting, check out our digest here 👉 bit.ly/3XvBUkp. We included talks from @jimallisonphd.bsky.social, @danielathommen.bsky.social, @jcstark.bsky.social#AACRIO25and more! (1/2)

📚 In conjunction with #ESMOImmuno24, we had our annual #ESMO #IOTECH Editorial Board meeting today - delighted to see many more academics now here 🦋. 🎯 EiC: @haanenjohn.bsky.social Section Editors: @michalbassani.bsky.social (NeoAg/TILs) @danielathommen.bsky.social (Biomarkers/novel IO targets)...

🎬 Fantastic start to #ESMOImmuno24 with ESMO-SITC primer. Highlighting challenges of IO biomarker discovery: 🔴 Heterogeneity in data, samples and assay types 🧬 Need for cross-study harmonisation & tailored composite biomarkers 💊 Neoadj. trials & PDTF’s offer opportunities for biomarker discovery!

Future PhD students, check out our NKI PhD program: bsky.app/profile/nkin...